Are experimental protocols an authentic simile of human diabetes?
DOI:
https://doi.org/10.29059/cienciauat.v14i2.1289Keywords:
experimental models, diabetes, alloxan, streptozotocin, hyperglycemiaAbstract
For the study of diabetes, several methodological strategies use animal models. Such methodologies involve surgical techniques, diet modifications, some genetic manipulations and specific toxic drugs. The experimental production of diabetes in animal models use the administration of alloxan or streptozotocin and these drugs produce irreversible damage to pancreatic -cells. However, its use is associated to a ketosis high mortality rate due to the acute damage of pancreatic cells. The aim of this review consisted in the analysis of the pharmacological diabetes production protocols as well as other available strategies, in order to elucidate which is potentially the ideal protocol that emulates human diabetes. Diabetes is a progressive and chronic process, in which most of the clinical alterations are a long-term consequence of micro and macrovascular alterations. Therefore, it is convenient to establish a difference between the effects of acute hyperglycemia, with those effects observable when hyperglycemia is present over the long-term in order to reach enough analogies between the animal experimental model with the human diabetes syndrome, through the use of laboratory and clinical indicators commonly employed for the diagnoses and management of human diabetes.
References
Acharjee, S., Ghosh, B., Al-Dhubiab, B. E., and Nair, A. B. (2013). Understanding type 1 diabetes: etiology and models. Canadian Journal of Diabetes. 37(4): 269-276.
Al-Awar, A., Kupai, K., Veszelka, M., Szűcs, G., Attieh, Z., Murlasits, Z., …, and Varga, C. (2016). Experimental diabetes mellitus in different animal models. Journal of Diabetes Research. 2016: 9051426.
Arias-Díaz, J. and Balibrea, J. (2007). Modelos animales de intolerancia a la glucosa y diabetes tipo 2. Nutrición Hospitalaria. 22(2): 160-168.
Barbour, L. A. (2019). Metabolic culprits in obese pregnancies and gestational diabetes mellitus: big babies, big twists, big picture: The 2018 Norbert Freinkel Award Lecture. Diabetes Care. 42(5): 718-726.
Barriere, D. A., Noll, C., Roussy, G., Lizotte, F., Kessai, A., Kirby, K., ..., and Sarret, P. (2018). Combination of high-fat/high-fructose diet and low-dose streptozotocin to model longterm type-2 diabetes complications. Scientific Reports. 8(1): 424.
Benomar, Y. and Taouis, M. (2019). Molecular mechanisms underlying obesity-induced hypothalamic inflammation and insulin resistance: pivotal role of resistin/TLR4 pathways. Frontiers in Endocrinology. 10: 140.
Boles, A., Kandimalla, R., and Reddy, P. H. (2017). Dynamics of diabetes and obesity: Epidemiological perspective. Biochimical et Biophysica Acta Molecular Basis Disease. 1863(5): 1026-1036.
Brito-Casillas, Y., Melián, C., and Wägner, A. M. (2016). Study of the pathogenesis and treatment of diabetes mellitus through animal models. Endocrinololgía y Nutrición. 63(7): 345-353.
Burbridge, S., Stewart, I., and Placzek, M. (2016). Development of the neuroendocrine hypothalamus. Comprehensive Physiology. 6(2): 623-643.
Buyukdere, Y., Gulec, A., and Akyol, A. (2019). Cafeteria diet increased adiposity in comparison to high fat diet in young male rats. PeerJ. 7: e6656.
Carrero, J. A., McCarthy, D. P., Ferris, S. T., Wan, X., Hu, H., Zinselmeyer, B. H., …, and Unanue, E. R. (2017). Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice. Proceedings of the National Academy of Sciences of the United States of America. 114(48): E10418-E10427.
Castell-Auví, A., Cedó, L., Pallarès, V., Blay, M., Ardévol, A., and Pinent, M. (2012). The effects of a cafeteria diet on insulin production and clearance in rats. The British Journal of Nutrition. 108(7): 1155-1162.
Chan, M. (2017). Obesity and Diabetes: The Slow-Motion Disaster. Milbank Q. 95(1): 11-14.
Chen, Y. W., Fiscella, K. A., Bacharach, S. Z., and Calu, D. J. (2014). Effect of cafeteria diet history on cue-, pellet-priming-, and stress-induced reinstatement of food seeking infemale rats. PloS One. 9(7): e102213.
Chittka, D., Banas, B., Lennartz, L., Putz, F. J., Eidenschink, K., Beck, S., …, and Banas, M. C. (2018). Long-term expression of glomerular genes in diabetic nephropathy. Nephrology, Dialysis, Transplantation. 33(9): 1533-1544.
Churruca, I., Portillo, M. P., Casis, L., Gutierrez, A., Macarulla, M. T., and Echevarria, E. (2008). Effects of fluoxetine administration on hypothalamic melanocortin system in obese Zucker rats. Neuropeptides. 42(3): 293-299.
Contreras, C. M. and Gutiérrez-García, A. G. (2017). Cognitive impairment in diabetes and poor glucose utilization in the intracellular neural milieu. Med Hypotheses. 104: 160-165.
Contreras, C. M., Gutiérrez-García, A. G., and Moreno-Cortés, M. L. (2019). Responsivity of lateral septum-mPFC connections in alloxan-induced hyperglycemia. Behavioural Brain Research. 368: 111919.
Daryabor, G., Kabelitz, D., and Kalantar, K. (2019). An update on immune dysregulation in obesity-related insulin resistance. Scandinavian Journal of Immunology. 89(4): e12747.
Drel, V. R., Mashtalir, N., Ilnytska, O., Shin, J., Li, F., Lyzogubov, V. V., and Obrosova, I. G. (2006). The leptindeficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes. 55(12): 3335-3343.
Dunn, J. S., Sheehan, H. L., and McLetchie, N. G. B. (1943). Necrosis of islets of Langerhans produced experimentally. Lancet. 241 (6242): 484-487.
Federiuk, I. F., Casey, H. M., Quinn, M. J., Wood, M. D., and Ward, W. K. (2004). Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment. Comparative Medicine. 54(3): 252-257.
Flores, Y. N., Contreras, Z. A., Ramirez-Palacios, P., Morales, L. S., Edwards, T. C., Gallegos-Carrillo, K., …, and Patrick, D. L. (2019). Increased prevalence of psychosocial, behavioral, and socio-environmental risk factors among over-weight and obese youths in Mexico and the United States. International Journal of Environmental Research and Public Health. 16(9): E1534.
Fu, Z., Gilbert, E. R., and Liu, D. (2013). Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Current Diabetes Reviews. 9(1): 25-53.
Geiss, L. S., Kirtland, K., Lin, J., Shrestha, S., Thompson, T., Albright, A., and Gregg, E. W. (2017). Changes in diagnosed diabetes, obesity, and physical inactivity prevalence in US counties, 2004-2012. PLoS One. 12(3): e0173428.
Gerber, P. A. and Rutter, G. A. (2017). The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxidants & Redox Signaling. 26(10): 501-518.
Gómez-Smith, M., Karthikeyan, S., Jeffers, M. S., Janik, R., Thomason, L. A., Stefanovic, B., and Corbett, D. (2016). A physiological characterization of the Cafeteria diet model of metabolic syndrome in the rat. Physiology and Behavior. 167: 382-391.
Grillo, C. A., Piroli, G. G., Lawrence, R. C., Wrighten, S. A., Green, A. J., Wilson, S. P., ..., and Reagan, L. P. (2015). Hippocampal insulin resistance impairs spatial learning and synaptic plasticity. Diabetes. 64(11): 3927-3936.
Grillo, C. A., Woodruff, J., Macht, V. A., and Reagan, L. P. (2019). Insulin resistance and hippocampal dysfunction: Disentangling peripheral and brain causes from consequences. Experimental Neurology. 318: 71-77.
Guex, C. G., Reginato, F. Z., de-Jesus, P. R., Brondani, J. C., Lopes, G. H. H., and Bauermann, L. F. (2019). Antidiabetic effects of Olea europaea L. leaves in diabetic rats induced by high-fat diet and low-dose streptozotocin. Journal of Ethnopharmacology. 235: 1-7.
Gutiérrez, A., Saracibar, G., Casis, L., Echevarria, E., Rodriguez, V. M., Macarulla, M. T., ..., and Portillo, M. P. (2002). Effects of fluoxetine administration on neuropeptide y and orexins in obese zucker rat hypothalamus. Obesity Research. 10(6): 532-540.
Harwood, H. J., Listrani, P., and Wagner, J. D. (2012). Nonhuman primates and other animal models in diabetes research. Journal of Diabetes Science and Technology. 6(3): 503-514.
Hascup, E. R., Broderick, S. O., Russell, M. K., Fang, Y., Bartke, A., Boger, H. A., and Hascup, K. N. (2019). Dietinduced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in AbetaPP/PS1 mice. Journal of Neurochemistry. 148(2): 219-237.
Heyne, A., Kiesselbach, C., Sahún, I., McDonald, J., Gaiffi, M., Dierssen, M., and Wolffgramm, J. (2009). An animal model of compulsive food-taking behaviour. Addiction Biology. 14(4): 373-383.
Hugés-Hernandorena, B., Rodríguez-García, J. C., Rodríguez-González, J. C., and Marrero-Rodríguez, M. T. (2002). Animales de experimentación como modelos de diabetes mellitus tipo 2. Revista Cubana de Endocrinología. 13(2): 160-168.
Igel, M., Becker, W., Herberg, L., and Joost, H. G. (1997). Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse. Endocrinology. 138(10): 4234-4239.
Kahn, S. E., Hull, R. L., and Utzschneider, K. M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 444(7121): 840-846.
Karatas, F., Sahin, S., Aytekin, A., Hacioglu, M. B., Imamoglu, G. I., and Altinbas, M. (2018). Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma. Journal of Cancer Research and Therapeutics. 14(5): 1149-1151.
Kaur, M., Bedi, O., Sachdeva, S., Reddy, B. V. K. K., and Kumar, P. (2014). Rodent animal models: from mild to advanced stages of diabetic nephropathy. Inflammopharmacology. 22(5): 279-293.
Kim, B., Elzinga, S. E., Henn, R. E., McGinley, L. M., and Feldman, E. L. (2019). The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer’s disease. Neurobiology of Disease. 132: 104541.
Lascar, N., Altaf, Q. A., Raymond, N. T., Broen, J., Pattison, H., Barnett, A., ..., and Bellary, S. (2019). Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes. Current Medical Research and Opinion. 1-8.
Lenzen, S. (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 51(2): 216-226.
Lewis, A. R., Singh, S., and Youssef, F. F. (2019). Cafeteria-diet induced obesity results in impaired cognitive functioning in a rodent model. Heliyon. 5(3): e01412.
Liljedahl, L., Norlin, J., McGuire, J. N., and James, P. (2017). Effects of insulin and the glucagon-like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice. Physiology Reproduction. 5(6): e13187.
Lucchesi, A. N., Cassettari, L. L., and Spadella, C. T. (2015). Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. Journal of Diabetes Research. 2015: 494578.
Lucchesi, A. N., Freitas, N. T., Cassettari, L. L., Marques, S. F., and Spadella, C. T. (2013). Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. Acta Cirurgica Brasileira. 28(7): 502-508.
Minkowski, O. and Bretzel, R. G. (2002). Further reports on diabetes mellitus after the extirpation of the pancreas. Journal of Molecular Medicine (Berlin, Germany). 80(1): 3-4.
Moreno-Cortés, M. L., Gutiérrez-García, A. G., Guillén-Ruiz, G., Romo-González, T., and Contreras, C. M. (2016). Widespread blunting of hypothalamic and amygdala-septal activity and behavior in rats with long-term hyperglycemia. Behavioural Brain Research. 310: 59-67.
Mtintsilana, A., Micklesfield, L. K., Chorell, E., Olsson, T., and Goedecke, J. H. (2019). Fat redistribution and accumulation of visceral adipose tissue predicts type 2 diabetes risk in middle-aged black South African women: a 13-year longitudinal study. Nutrition and Diabetes. 9(1): 12.
Necyk, C. and Zubach-Cassano, L. (2017). Natural health products and diabetes: a practical review. Canadian Journal of Diabetes. 41(6): 642-647.
Norwitz, N. G., Mota, A. S., Norwitz, S. G., and Clarke, K. (2019). Multi-Loop model of Alzheimer disease: an integrated perspective on the Wnt/GSK3beta, alpha-synuclein, and type 3 diabetes bypotheses. Frontiers in Aging Neuroscience. 11: 184.
Okamura, T., Hashimoto, Y., Hamaguchi, M., Obora, A., Kojima, T., and Fukui, M. (2019). Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: apopulationbased longitudinal study. International Journal of Obesity. 43(1): 139-148.
Ono, H. (2019). Molecular mechanisms of hypothalamic insulin resistance. International Journal of Molecular Sciences. 20(6): E1317.
Ozlu, E., Uzuncakmak, T. K., Takir, M., Akdeniz, N., and Karadag, A. S. (2018). Comparison of cutaneous manifestations in diabetic and nondiabetic obese patients: A prospective, controlled study. Northern Clinics of Istanbul. 5(2): 114-119.
Park, Y. W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., and Heymsfield, S. B. (2003). The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Archives International of Medicine. 163(2003): 427-436.
Prakash, L., Bhosale, P., Cloyd, J., Kim, M., Parker, N., Yao, J., ..., and Katz, M. H. (2017). Role of fluorouracil, doxorubicin, and streptozocin therapy in the preoperative treatment of localized pancreatic neuroendocrine tumors. Journal of Gastrointestinal Surgery. 21(1): 155-163.
Radenković, M., Stojanović, M., and Prostran, M. (2016). Experimental diabetes induced by alloxan and streptozotocin: The current state of the art. Journal and Pharmacological and Toxicological Methods. 78: 13-31.
Rawshani, A., Sattar, N., Franzén, S., Rawshani, A., Hattersley, A. T., Svensson, A. M., ..., and Gudbjörnsdottir, S. (2018). Excess mortality and cardiovascular disease in Young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 392(10146): 477-486.
Rerup, C. C (1970). Drugs producing diabetes through damage of the insulin secreting cells. Pharmacology Review. 22(4): 485-518.
Sah, S. P., Singh, B., Choudhary, S., and Kumar, A. (2016). Animal models of insulin resistance: A review. Pharmacological Reports: PR. 68(6): 1165-1177.
Saltiel, A. R. and Olefsky, J. M. (2017). Inflammatory mechanisms linking obesity and metabolic disease. Journal Clinical Investigation. 127(1): 1-4.
Sankrityayan, H., Oza, M. J., Kulkarni, Y. A., Mulay, S. R., and Gaikwad, A. B. (2019). ER stress response mediates diabetic microvascular complications. Drug Discovery Today. 1359-6446(19): 30314-30319.
Sharma, G., Ashhar, M. U., Aeri, V., and Katare, D. P. (2019). Development and characterization of late-stage diabetes mellitus and associated vascular complications. Life Sciences. 216: 295-304.
Sharma, K., McCue, P., and Dunn, S. R. (2003). Diabetic kidney disease in the db/db mouse. American Journal of Physiology. Renal Physiology. 284(6): F1138-F1144.
Shivaswamy, V., Boerner, B., and Larsen, J. (2016). Post-Transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocrinology Review. 37(1): 37-61.
Soto, M., Cai, W., Konishi, M., and Kahn, C. R. (2019). Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. Proceeding of the National Academy of Sciences of the United States America. 116(13): 6379-6384.
Spurr, S., Bally, J., Allan, D., Bullin, C., and McNair, E. (2019). Prediabetes: An emerging public health concern in adolescents. Endocrinology, Diabetes and Metabolism. 2(2): e00060.
Srinivasan, K. and Ramarao, P. (2007). Animal models in type 2 diabetes research: an overview. The Indian of Journal of Medical Research. 125(3): 451-472.
Staats, J. (1975). Diabetes in the mouse due to two mutan genes - a bibliography. Diabetologia. 11(4): 325-327.
Stein, A. D., Obrutu, O. E., Behere, R. V., and Yajnik, C. S. (2019). Developmental undernutrition, offspring obesity and type 2 diabetes. Diabetologia. 62(10): 1773-1778.
Szkudelski, T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research. 50(6): 537-546.
Tamas, M. J., Khakharia, A., Rothenberg, R. B., and Phillips, L. S. (2018). Weight trends in veterans with and without diabetes, 2000 to 2014. Obesity. 26(12): 1949-1957.
Tancredi, M., Rosengren, A., Svensson, A. M., Kosiborod, M., Pivodic, A., Gudbjörnsdottir, S., …, and Lind, M. (2015).
Excess mortality among persons with Type 2 diabetes. The New England Journal of Medical. 373(18): 1720-1732.
Waernbaum, I., Dahlquist, G., and Lind, T. (2019). Perinatal risk factors for type 1 diabetes revisited: a populationbased register study. Diabetologia. 1-12.
Wells, J. C. K. (2019). The diabesity epidemic in the light of evolution: insights from the capacity-load model. Diabetologia. 62(10): 1740-1750.
Wilson, R. D. and Islam, M. S. (2012). Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. Pharmacological Reports: PR. 64(1): 129-139.
Winocur, G., Greenwood, C. E., Piroli, G. G., Grillo, C. A., Reznikov, L. R., Reagan, L. P., and McEwen, B. S. (2005). Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behavioral Neuroscience. 119(5): 1389-1395.
Wojciechowska, J., Krajewski, W., Bolanowski, M., Kręcicki, T., and Zatoński, T. (2016). Diabetes and Cancer: a review of current knowledge. Experimental Clinical Endocrinology Diabetes. 124(5): 263-275.
Yu, Y. B., Bian, J. M., and Gu, D. H. (2015). Transplantation of insulin-producing cells to treat diabetic rats after 90 % pancreatectomy. World Journal of Gastroenterology. 21(21): 6582-6590.
Zhou, W., Wei, L., Xiao, T., Lai, C., Peng, M., Xu, L., …, and Zhang, F. (2017). Diabetogenic agent alloxan is a proteasome inhibitor. Biochemical and Biophysical Research Communications. 488(2): 400-406.
